In conclusion, based on our data, we hypothesize that the CRC-associated microbiome directly or by releasing bacteria-derived substances (i.e., LPS, ROS, etc.)might promote intestinal lumen inflammation and induce the CCL2 transcription by cells in the tumor microenvironment. The gene discussed is CCL2; the disease is neoplasm.